A detailed history of Dowling & Yahnke LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Dowling & Yahnke LLC holds 4,343 shares of EW stock, worth $327,375. This represents 0.17% of its overall portfolio holdings.

Number of Shares
4,343
Previous 4,265 1.83%
Holding current value
$327,375
Previous $406,000 11.58%
% of portfolio
0.17%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

BUY
$82.37 - $107.29 $6,424 - $8,368
78 Added 1.83%
4,343 $359,000
Q2 2022

Aug 10, 2022

SELL
$86.5 - $128.27 $8,304 - $12,313
-96 Reduced 2.2%
4,265 $406,000
Q1 2022

May 04, 2022

BUY
$101.96 - $128.34 $40,784 - $51,336
400 Added 10.1%
4,361 $513,000
Q4 2021

Feb 10, 2022

SELL
$106.37 - $130.68 $3,403 - $4,181
-32 Reduced 0.8%
3,961 $513,000
Q2 2021

Jul 21, 2021

SELL
$83.84 - $104.76 $12,995 - $16,237
-155 Reduced 3.74%
3,993 $414,000
Q1 2021

Apr 29, 2021

BUY
$78.68 - $90.67 $7,946 - $9,157
101 Added 2.5%
4,148 $347,000
Q4 2020

Jan 28, 2021

BUY
$71.69 - $91.23 $64,521 - $82,107
900 Added 28.6%
4,047 $369,000
Q3 2020

Oct 19, 2020

BUY
$67.19 - $87.44 $4,434 - $5,771
66 Added 2.14%
3,147 $251,000
Q2 2020

Jul 31, 2020

BUY
$57.54 - $76.95 $177,280 - $237,082
3,081 New
3,081 $213,000
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $55,659 - $86,022
-1,062 Closed
0 $0
Q4 2019

Jan 27, 2020

SELL
$71.7 - $82.09 $573 - $656
-8 Reduced 0.75%
1,062 $248,000
Q3 2019

Oct 29, 2019

BUY
$61.55 - $75.43 $65,858 - $80,710
1,070 New
1,070 $235,000
Q1 2018

May 01, 2018

SELL
$37.19 - $47.45 $71,999 - $91,863
-1,936 Closed
0 $0
Q4 2017

Feb 02, 2018

BUY
$33.79 - $39.39 $65,417 - $76,259
1,936
1,936 $218,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Dowling & Yahnke LLC Portfolio

Follow Dowling & Yahnke LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.